Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care. We work in over 50 countries and serve patients in more than 140 countries. Each year we commit a substantial amount in Research and Development to meet customer needs and patient demands.
SABIC is a global diversified chemicals company, headquartered in Riyadh, Saudi Arabia. It manufactures on a global scale in the Americas, Europe, Middle East and Asia Pacific, making distinctly different kinds of products: chemicals, commodity and high performance plastics, agri-nutrients and metals.
The company has more than 32,000 employees worldwide, serving customers in more than 140 countries.
A trusted partner for millions of customers, Ecolab is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on a century of innovation, Ecolab has annual sales of $14 billion, employs more than 47,000 associates and operates in more than 170 countries around the world.
Arkema ist ein globaler Designer von Materialien und innovativen Lösungen und in Deutschland mit rund 400 Mitarbeitern an 6 Standorten vertreten (Düsseldorf, Günzburg, Kirchheimbolanden, Leuna, Vastorf, Zwickau).
Die Aktivitäten der Bostik werden in diversen Tochtergesellschaften der Arkema GmbH geführt. Diese beschäftigen weitere ca. 650 Mitarbeiter in Deutschland, Österreich und Schweiz.
En Alcon, líder mundial en el cuidado de la visión, queremos mejorar la vida de las personas. Con más de 75 años de historia y dos divisiones de negocio, Cirugía y Vision Care, somos la mayor empresa mundial del sector.
Diversey is a leading global pure play provider to the cleaning and hygiene industry for the institutional and food and beverage markets. We provide customers peace of mind by helping maintain their brand integrity so they can focus on growing their business. Through end-to-end repeatable services we deliver the highest standards across customer locations to achieve improved operational efficiency and environmental sustainability.
The mission of our governance system is to create shared value for all our stakeholders. To do so, corporate governance is committed to assessing the constantly evolving environment in which we do business to ensure that growth continues and to strengthen our relationship with the local community.
Chiesi is a research-oriented, international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment.
El Grupo Vall Companys es un grupo agroalimentario de carácter familiar y líder en España, fundado en 1956.
El modelo operacional del Grupo Vall Companys se basa en la integración de todas las fases del proceso productivo, así como en la labor de unos profesionales implicados y altamente formados en sus respectivos campos de actividad.
Nous fournissons des peintures et revêtements durables et innovants sur lesquels comptent de plus en plus nos clients, nos communautés et notre société. Nos clients du monde entier font confiance à notre portefeuille de marques internationales, notamment Dulux, International, Sikkens et Interpon. Nous sommes présents dans plus de 150 pays.
TotalEnergies Marketing South Africa was established in 1954 and is 50.1% owned by multi-national Paris-based Company, TotalEnergies company. TotalEnergies Marketing South Africa (PTY) Ltd is a significant role player within the TotalEnergies company.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience and Gastroenterology. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.